861998-00-7 Usage
Uses
Used in Oncology:
AnaMorelin hydrochloride is used as a potential therapeutic agent for non-small cell lung cancer. It is believed to aid in the treatment of this condition by modulating the body's growth hormone secretion and potentially improving muscle strength, which can be compromised in cancer patients.
Used in Pulmonary Medicine:
In the field of pulmonary medicine, AnaMorelin hydrochloride is used as a potential treatment for chronic obstructive pulmonary disease (COPD). The drug's ability to stimulate growth hormone secretion and increase food intake may help in managing the symptoms and improving the overall quality of life for COPD patients.
Used in Endocrinology:
AnaMorelin hydrochloride is used as a treatment for cachexia, a condition characterized by severe weight loss and muscle wasting. As a ghrelin receptor agonist, it may help in increasing appetite and promoting weight gain, thereby alleviating the symptoms of cachexia.
Used in Clinical Research:
AnaMorelin hydrochloride is used as a subject of investigation in clinical trials. These trials aim to explore its potential benefits in various medical conditions, as well as to understand its mechanism of action and safety profile. This research is crucial for determining the drug's efficacy and potential side effects before it can be approved for widespread use in medical practice.
Check Digit Verification of cas no
The CAS Registry Mumber 861998-00-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,9,9 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 861998-00:
(8*8)+(7*6)+(6*1)+(5*9)+(4*9)+(3*8)+(2*0)+(1*0)=217
217 % 10 = 7
So 861998-00-7 is a valid CAS Registry Number.
861998-00-7Relevant academic research and scientific papers
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
-
Page/Page column 15-16, (2013/11/05)
The present invention relates to particulate forms of anamorelin monohydrochloride or a composition comprising anamorelin monohydrochloride having controlled chloride content, preferably isolated in an amorphous and/or fine particulate state, processes for making the particulate forms, and pharmaceutical compositions comprising the particulate forms.
